CR20150030A - ANTIGEN FIXING PROTEINS ANTAGONISTS OF THE DUAL ACTION RECEIVER AND ITS USES - Google Patents
ANTIGEN FIXING PROTEINS ANTAGONISTS OF THE DUAL ACTION RECEIVER AND ITS USESInfo
- Publication number
- CR20150030A CR20150030A CR20150030A CR20150030A CR20150030A CR 20150030 A CR20150030 A CR 20150030A CR 20150030 A CR20150030 A CR 20150030A CR 20150030 A CR20150030 A CR 20150030A CR 20150030 A CR20150030 A CR 20150030A
- Authority
- CR
- Costa Rica
- Prior art keywords
- dual action
- dual
- action receiver
- fixing proteins
- antigen fixing
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Esta descripción se refiere a proteínas fijadoras de antígeno del receptor de acción dual antagonista, por ejemplo anticuerpos y método para utilizar el anticuerpo de receptor de acción dual para el tratamiento de enfermedades patológicas. El anticuerpo del receptor de acción dual puede comprender un anticuerpo para receptores ActRII y también puede utilizarse para tratar una condición patológica. Las condiciones patológicas pueden comprender enfermedades de desgaste muscular o cualquier enfermedad que requiera la estimulación del crecimiento muscular.This description relates to antagonist dual action receptor antigen binding proteins, for example antibodies and method for using the dual action receptor antibody for the treatment of pathological diseases. The dual-action receptor antibody can comprise an antibody to ActRII receptors and can also be used to treat a pathological condition. Pathological conditions may include diseases of muscle wasting or any disease that requires stimulation of muscle growth.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CR20150030A CR20150030A (en) | 2015-01-23 | 2015-01-23 | ANTIGEN FIXING PROTEINS ANTAGONISTS OF THE DUAL ACTION RECEIVER AND ITS USES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CR20150030A CR20150030A (en) | 2015-01-23 | 2015-01-23 | ANTIGEN FIXING PROTEINS ANTAGONISTS OF THE DUAL ACTION RECEIVER AND ITS USES |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20150030A true CR20150030A (en) | 2016-04-07 |
Family
ID=56103156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20150030A CR20150030A (en) | 2015-01-23 | 2015-01-23 | ANTIGEN FIXING PROTEINS ANTAGONISTS OF THE DUAL ACTION RECEIVER AND ITS USES |
Country Status (1)
Country | Link |
---|---|
CR (1) | CR20150030A (en) |
-
2015
- 2015-01-23 CR CR20150030A patent/CR20150030A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO7240399A2 (en) | Dual-acting receptor antagonist antigen binding proteins and their uses | |
ECSP17063327A (en) | ANTIDLL3 CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE | |
CY1124787T1 (en) | ANTI-GITR ANTIBODIES AND METHODS OF USING THEM | |
UY36942A (en) | ANTIGEN UNION PROTEINS THAT ACTIVATE THE LEPTINE RECEIVER | |
CR20190071A (en) | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES | |
CL2017001217A1 (en) | Antibody drug conjugates. | |
BR112017013176A2 (en) | chimeric antigen receptors and methods for using them | |
CO2018014010A2 (en) | Alpha-synuclein antibodies and uses thereof | |
CL2019000799A1 (en) | Antibodies and fragments thereof that bind to the human cannabinoid 1 (cb1) receptor. (divisional application 201602433) | |
ECSP16089579A (en) | PROTEINS AGONISTS OF SINGLE CHAIN TRAIL RECEPTORS. | |
ECSP10010322A (en) | ANTIBODIES AGAINST THE INFLUENZA VIRUS AND METHODS OF USE OF THE SAME | |
PE20161210A1 (en) | ANTI-MCAM ANTIBODIES AND ASSOCIATED METHODS OF USE | |
MX2019008722A (en) | Glucagon receptor binding proteins and methods of use thereof. | |
MX2022002056A (en) | Compounds for the treatment of bovine or swine respiratory disease. | |
NI202000051A (en) | MONOCLONAL ANTIBODIES AND METHODS FOR USING THE SAME. | |
BR112017024852A2 (en) | Double nk-1 / nk-3 receptor antagonists for the treatment of sex hormone dependent diseases | |
CO2020000260A2 (en) | Chimeric antibodies for the treatment of amyloid deposition diseases | |
CR20190086A (en) | Antibody or an antigen-binding fragment thereof capable of binding to a human receptor of interleukin-6 | |
EA201792312A1 (en) | CONSTRUCTIONS BASED ON KALIHEAMICIN AND METHODS OF THEIR APPLICATION | |
BR112019011461A2 (en) | improved nk-based cell therapy | |
BR112018072697A2 (en) | composition, and method for treating a disease in a subject | |
CR20150030A (en) | ANTIGEN FIXING PROTEINS ANTAGONISTS OF THE DUAL ACTION RECEIVER AND ITS USES | |
EA201692564A1 (en) | COMBINED THERAPY | |
EA202190504A1 (en) | METHODS FOR TREATMENT OF PSORIASIS | |
AR115992A2 (en) | ANTIGEN BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTOR |